Correlation Engine 2.0
Clear Search sequence regions


  • BRCA1 (6)
  • brca2 protein (2)
  • diagnosis (1)
  • female (1)
  • humans (1)
  • patients (1)
  • pregnancy (2)
  • protein human (1)
  • research (1)
  • Sizes of these terms reflect their relevance to your search.

    The detection of germline BRCA1/2 pathogenic variant has relevant implications for the patients and their family members. Family planning, prophylactic surgery and the possibility of preimplantation genetic testing for monogenic disorders (PGT-M) to avoid transmittance of pathogenic variants to the offspring are relevant topics in this setting. PGT-M is valuable option for BRCA carriers, but it remains a controversial and underdiscussed topic. Although the advances in PGT technologies have improved pregnancy rate, there are still several important challenges associated with its use. The purpose of this review is to report the current evidence on PGT-M for BRCA1/2 carriers, ethical concerns and controversy associated with its use, reproductive implications of BRCA pathogenic variants, underlying areas in which an educational effort would be beneficial as well as possibilities for future research efforts in the field. Copyright © 2020 Elsevier B.V. All rights reserved.

    Citation

    Petra Vuković, Fedro Alessandro Peccatori, Claudia Massarotti, Manuel Selvi Miralles, Lidija Beketić-Orešković, Matteo Lambertini. Preimplantation genetic testing for carriers of BRCA1/2 pathogenic variants. Critical reviews in oncology/hematology. 2021 Jan;157:103201

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 33333149

    View Full Text